Best Accredited Universities for Doctoral Phd program in Molecular Medicine

Gozde Durmus, PhD, Selected as a 2021 Moore Inventor Fellow.

The Division of Molecular Imaging Program at Stanford (MIPS) in the Radiology is an inter-disciplinary program to bring together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technologies and developing molecular imaging assays for studying intact biological systems.

Topics in Molecular Medicine (TiMM) is planned as a seminar course whose goal is to introduce students to the ways in which biomedical research can provide new insights into clinical medicine and, conversely, how knowledge of clinical disease impacts scientific discovery.Due to space limitations, the course is open only to 1st year Combined Degree (MD PhD) students.

The course will be in a seminar style. The team involved in presentation involves ~4-5 students per session, with teams split between presenters and discussants.

The mission of the Molecular Medicine is to make fundamental discoveries in basic research that will be relevant to and impact the biomedical community educate and train graduate students, postdoctoral (PhD) and DVM fellows, and educate veterinary students in the basic biological concepts that underlie the development of treatment strategies.

The over-arching theme of the research being conducted in Molecular Medicine is to obtain basic understandings of protein structure and function, protein-protein, and protein-membrane interactions as they pertain to fundamental processes in cell and developmental biology.

Integrated Program in Cellular, Molecular, and Biomedical Studies.

The Pathobiology and Mechanisms of Disease Program is designed to give PhD students a strong background in graduate-level biology. We have created a curriculum that deeply examines the basic science, clinical, and social implications of a number of diseases in great detail. Diseases like sickle cell anemia, atherosclerosis, Alzheimer disease, neuromuscular diseases, liver diseases, diabetes, and diseases of the eye are major areas of research focus. Our program aims at a new approach to converting basic research of disease into clinically relevant results. Alumni have gone on to important positions in academia, government, and industry.

The Program in Biomedical Sciences at the University of Michigan is an interdisciplinary gateway program that coordinates admissions and the first year of Ph.D. studies for 13 department programs, including Molecular Cellular Pathology.

PIBS offers you the flexibility and convenience of applying to any of our participating programs through one application. We invite you to thoroughly explore Molecular Cellular Pathology and the other programs before selecting your top preferences when you apply.

The Molecular and Cellular Pathology Graduate Program is situated in the Pathology and takes advantage of its unique position in a department that bridges basic and clinical sciences to encourage interdisciplinary projects and interdepartmental cooperation. A variety of educational experiences are offered with the objective that persons destined for research careers have a better understanding of disease-related clinical problems.

The primary goal of the doctoral program is to train individuals for careers as independent scientific investigators in academic or biotechnology sectors, with a focus on the study of the molecular and cellular mechanisms of disease processes.

The graduate program in Molecular Cellular Pathology focuses on the comprehensive study of the pathogenesis of human diseases and its application to the understanding, prevention, diagnosis and treatment of human diseases.

The required core courses provide students with a background in basic areas of biochemistry, cell biology, immunology, and human genetics, providing a rigorous intellectual foundation in preparation for in-depth study of the cellular and molecular pathogenesis of disease. This multi-disciplinary course trains both graduate students and clinical residents fellows in the methods and principles involved in translating basic science findings into clinically useful interventions to improve human disease outcomes. Students also have the flexibility to select electives reflecting their own interest from a wide array of specialized courses offered at the Medical School and throughout the University.

The MCP graduate program has no formal teaching requirement, but will provide access and training to individuals that want a teaching experience.

Program is designed for students to graduate in five years of training.

MCP students have been recognized for their successes through institutional and national awards including Rackham Research and Travel Grants, Rackham Distinguished Dissertation Awards, and Rackham Predoctoral Fellowships. They have also earned training positions on competitive NIH training grants, Ruth L. Kirschstein National Research Science Awards as well as awards from professional societies. The MCP graduate students produce high quality research that has resulted in publications in top tier journals such as Science, Nature, Nature Medicine, Cell, Cancer Cell, Molecular Cell, NEJM, and PNAS and presentations at multiple venues at the U-M and other national and international venues.

Our Molecular Cellular Pathology program prepares students for careers in academia, biotech, pharmaceutical industry, education, publishing, and public policy. Many of our Ph.D. graduates pursue careers in industry and government, in addition to academic teaching and research. The training students receive in disease models and processes has made them invaluable in assessing drug efficacy and toxicity consequently, a significant number of these individuals take positions in biotech and pharmaceutical companies. Governmental research and regulatory agencies also benefit from this expertise, partly for the same reasons as the drug companies, and also for their basic and applied research skills.

Research and Education at the forefront of Biochemistry Molecular Biology.

Designed to provide students the necessary skills to obtain positions within the private and government research sectors as well as provide the background necessary for entry into competitive Ph.D. or other professional school (MD, DVM, DDS, etc) programs.

Students joining the Graduate Program in Biomedical Sciences with a concentration in Biochemistry and Molecular Biology (BMB) are given maximum flexibility to pursue a wide-range of research and curriculum opportunities.

Distance learning courses are offered to UF students in online degree programs, MS and BS, or non-degree seeking students and are delivered online. Our courses follow a traditional UF semester calendar.

PHENOTYPIC PERSONALIZED MEDICINE TO GUIDE IMMUNOSUPPRESSION MANAGEMENT IN KIDNEY AND LIVER TRANSPLANTATION.

The Graduate Program in Molecular Translational Medicine (MTM) at Boston University is an interdisciplinary program based in the Medicine. The overarching goal of the MTM graduate program is to train students to lead hypothesis-driven investigations into the mechanisms of human disease.

Molecular Translational Medicine curriculum includes the following courses:.

During the first year and intervening summer, students rotate in different laboratories within the Medicine or affiliated laboratories and choose a laboratory where they will conduct their research leading to a dissertation. In the fall of their second year, students take the Tier 1 Qualifying Examination, which is a review of a scientific paper in an examination format. Following completion of all coursework, students write and orally defend their Tier 2 Qualifying Examination, which is a mock research proposal in an F31 format on the topic of their dissertation research.

Students are expected to participate in the MTM Colloquium, BUSM seminars, ARCs, the annual Evans Medicine Research Days, and the Henry I. Russek Student Achievement Day.

Candidates for a PhD in Molecular Translational Medicine will have varied scientific and medical backgrounds. The program of study must be approved by the Student Performance Committee.

The Graduate Program in Molecular Translational Medicine participates in the Program in Biomedical Sciences (PiBS), which offers training towards the PhD degree by integrating the foundations of interdisciplinary biomedical research with focused investigation and preparation for career advancement. The PhD program is divided into three parts: Part I, Basic Science Curriculum Part II, Molecular Translational Medicine Curriculum and Part III, Dissertation Research. After successful completion of Parts I and II and prior to officially initiating dissertation research, each candidate will be expected to complete the Tier 2 Qualifying Examination.

The first-year basic science curriculum for almost all PhD programs and departments is set up as one major course called Foundations in Biomedical Sciences (FBS) that runs the full academic year, with a September start date. This innovative and interdisciplinary core course will encompass material that has been traditionally taught in courses of biochemistry, cell biology, genetics and genomics, and molecular biology. These four major topics will be taught as sequential modules. A fifth module will be available as well with a choice of topics, from development and stem cells to physiology and metabolism. This should be a particularly exciting student experience across the graduate school at BUSM. The goals of this new curriculum are to encourage students to think in a rigorous and interdisciplinary fashion coordinate content across courses and programs reduce redundancy in course content decrease lecture hours and promote collegiality among participating doctoral students.

MTM curriculum consists of two semesters covering topics on the scientific basis and research methodology of the molecular basis of disease and foundations for translational applications. These courses are taught as advanced graduate seminars. They are required of all MTM students in the second year and are open to other students in the Graduate Medical Sciences.

Six courses are offered that address major fields in the molecular basis of human disease: GMS MM 701, 703, 707, 710, 725, and 730. Each course will have its own outside reading.

Elective Spring semester, alternating years, next offered in spring 2022. The content of this course will introduce students to the structure and function of major organ systems including, but not limited to bone, heart, lungs, kidney, and brain and then interrogate how molecular and cellular disorders in these organs can lead to physiologic dysfunction and human disease. Examples of topics that will be covered include the molecular basis of sickle cell disease inflammatory bowel disease molecular basis of hematologic disorders amyloidosis endocrine dysfunction and cystic fibrosis.

GMS MM 710 Stem Cells and Regenerative Medicine (2 credits).

Elective Fall semester. This course will focus on technologies which are available at BUSM. Specific technologies include microscopy, FACS, IHC, qPCR, genomic (next gen sequencing and microarrays), proteomics techniques, HTS, fluorescence molecular tomography, ultrasound, and metabolic phenotyping techniques.

The Medicine occupies modern research laboratories on the Boston University Medical Campus in the Center for Advanced Biomedical Research and the Evans Biomedical Research Center. These buildings provide state-of-the-art research space in an open, spacious environment that is fully supported by research core facilities for computing, animals and transgenic mice, sequencing, microarrays, and others.

The Graduate Program in Molecular Translational Medicine avails itself of the Evans Center for Interdisciplinary Biomedical Research.

In addition, MDs who desire to pursue rigorous scientific training in preparation for a career in academic medicine and research are encouraged to apply. Students admitted to the program are offered full tuition support and an annual stipend.

Applicants interested in the Graduate Program in Molecular Translational Medicine should first-year Program in Biomedical Sciences (PiBS) through the Boston University School of Medicine Graduate Medical Sciences.

Note that this information may change at any time. Read the full terms of use.

School of Graduate StudiesToggle School of Graduate Studies.

Leadership Excel and Achievement Program (LEAP), Graduate Certificate.

Master of Science in Nursing, MSNToggle Master of Science in Nursing, MSN.

School of Dental MedicineToggle School of Dental Medicine.

Medical Scientist Training Program (MSTP)Toggle Medical Scientist Training Program (MSTP).

Molecular Biology and MicrobiologyToggle Molecular Biology and Microbiology.

Engr (IIME).

Degree: Doctor of Philosophy (PhD)Field of Study: Molecular Medicine.

Admission into the Molecular Medicine PhD program is obtained through application directly to the program. Graduate students complete didactic coursework, independent research, and other doctoral requirements to earn the PhD. The first year begins mid-July. Students from all years present their research and received feedback in the Student Seminar Series.

During subsequent years, students will devote the majority of their time to thesis research while attending advanced graduate courses, and seminars. Students must take a total of 36 semester hours of courses and pre-candidacy thesis research, including 24 graded credit hours, and maintain a B average.

All efforts should be made to complete the PhD within five years from the date of matriculation. All students are expected to submit two or first-authored primary research publications in peer-reviewed scientific journals. At least one manuscript must be accepted for publication prior to the thesis defense.

The emphasis of the PhD work is on research, culminating in the completion of an original, independent research thesis.

PRISM Program (Physicians Researchers Innovating in Science and Medicine).

NIH recognizes the need for physician on-ramps into research training, including the option for obtaining a PhD during residency fellowship. The Molecular Medicine PhD Program offers a track for Cleveland Clinic physician trainees in GME accredited programs, who wish to pursue a PhD in laboratory-based research in the Molecular Medicine PhD Program, a program completely housed and administered at the Cleveland Clinic.

For PhD policies and procedures, please review the School of Graduate Studies section of the General Bulletin.

Molecular aspects of the diagnosis, pathology, and treatment of selected human diseases.

Students begin in July by taking MMED 402 Tools for Research and MMED 410 Introduction to Human Physiology and Disease. The student will follow a progressive curriculum including Cell Biology Metabolism and Pharmacology Nucleic Acids, Gene Expression and Gene Regulation Mammalian Genetics and Infection and Immunity. In the second summer, students take Principles of Clinical and Translational Research. During year 2, students are required to take MMED 521 Molecular aspects of the diagnosis, pathology, and treatment of selected human diseases, focusing on molecular mechanisms of human disease, and an independent study mentored MMED 612 Clinical Experience.

Credits may vary to yield 9 credits per semester.

Third Year and beyond: Complete elective coursework so total graded courses equal at least 24 credits Research credits switch from MMED 601 Dissertation Research to MMED 701 Dissertation Ph.D. once passed into candidacy. Minimum of 1 credit of MMED 701 Dissertation Ph.D. is required each regular semester thereafter for a total of 18 credits to graduate.

The Biochemistry and Molecular Biology offers a program of study leading to a PhD degree within the framework of the Graduate Program in Biomedical Sciences. Areas of research strength include growth signaling and cancer, DNA and RNA binding proteins, and protein peptide structure, function and folding. Graduate training in the department draws on tools of modern biochemistry, molecular biology, genetics, cell biology, bioinformatics, biophysics and chemistry.

The training program is designed to ensure that every student receives broad training in biochemical sciences and achieves significant goals in a specialized field of research.

Doctoral students are required to complete core courses in the Biomedical Sciences Graduate Program (BMS) and advanced courses in biochemistry and molecular biology during the first two years of graduate training. Minimum requirements for the Ph.D. include 48 hours of formal course work, seminar presentations, scholarly conducted research and successful defense of a dissertation.

Ph.D. students admitted to the Biomedical Sciences (BMS) program are offered a tuition remission, a stipend for living expenses, and health insurance. They can choose to pursue their course of study and research training in the Biochemistry and Molecular Biology during the first year of their graduate program.

The Pharmacology and Physiology PhD program is centered on research that seeks to understand normal functions of systems within organisms and how these are altered by pathological states such as hypertension, stress, alcohol and exposure to endocrine disrupting chemicals and drugs. Many of these projects are integrative and emphasize the interactions between different systems.

Graduate students in the program can receive training in a variety of systems. These include the impact on the cardiovascular and renal systems in obesity and hypertension. Other areas include autonomic regulation of respiration and brainstem function, neural control of blood pressure and heart rate, post-traumatic stress disorder, cardiovascular diseases, and pharmacogenetic determinants of drug responses. Pharmacogenomics includes a study identifying genetic variants leading to increased health risks in African American populations.

The PhD in Pharmacology and Physiology begins with interdisciplinary coursework in molecular, cellular and systems biology in the first semester. In the second and third semester students take in-depth courses in pharmacogenomics, physiology and pharmacology.

BMSC 8210: Genes to CellsBMSC 8212: Systems PhysiologyBMSC 8230: Molecular Basis of Human DiseaseBMSC 8215: Laboratory Rotations (3)BMSC 8216: Career Skills: Scientific Writing and SpeakingBMSC 8217: Career Skills: Ethics and Grantsmanship.

PHAR 6116: Pharmacogenomics Personalized Medicine PHAR 6205: Pharmacology PHAR 8211: Physiology PHAR 8281: Molecular Pharmacology Neurobiology of Excitable Tissues.

to the IBS and Pharmacology and Physiology PhD Program.